Bristol-Myers Squibb Co
Bristol-Myers Squibb Co is a Pharmaceuticals company listed on NEW YORK STOCK EXCHANGE, INC..
About
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma ; ipilimumab (Yervoy), to treat cancer ; and luspatercept (Reblozyl) for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
via Wikipedia →Earnings (EPS)
Financial Highlights
The basics, explained simply — no finance degree required.
The lowest and highest price this stock has traded at over the past year.
How much this stock pays you back each year, just for holding it — as a % of the share price.
How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.
How much the company's sales grew compared to a year ago.
How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.
Insider Activity
Recent buys and sells by company executives and directors — publicly disclosed, as required by law.